ITGAM and cancer: FCM was used to identify the percentage of CD11b+CD66b+granulocytes and its apoptosis rate, and the results showed that the percentage of CD11b+CD66b+granulocytes was significantly increased, and its apoptosis rate was decreased in these three types of cancer (Fig. 2Aand2B).